by Steven Grossman | Oct 24, 2025 | Short Takes and Updates
Since the founding of our republic, there has been debate about states’ rights vs federal rights. And in times of stress, the discussion gets more heated and gains more traction. Once again, FDA is moving into the center of such debates. Federalism is at the Heart of...
by Steven Grossman | Oct 14, 2025 | Short Takes and Updates
The announcement that former CBER Director, Dr. Peter Marks, was joining Lilly as SVP for molecule discovery and head of infectious diseases….set the internet ablaze with unjustified outrage about his transition from a government career to industry. My multiple...
by Steven Grossman | Oct 13, 2025 | Uncategorized
This week’s questions:How long is the shutdown likely to continue?Did Commissioner Makary offer companies accelerated review if they make the pricing concessions requested by the Administration?Where does the farm community fit into the MAHA agenda?——Q: How long...
by Steven Grossman | Oct 10, 2025 | Short Takes and Updates
Every day, our country is failing patients with relentlessly progressive chronic neurological, neuromuscular, and genetic diseases. Their plight necessitates a significantly different risk-benefit calculation than that of patients with other types of diseases....
by Steven Grossman | Oct 6, 2025 | Uncategorized
This week’s questions:State public health officials are having to make difficult decisions about whether to follow CDC guidance on vaccines and other topics. Could there be a similar erosion of trust by states regarding FDA guidance?Anti-vaccine policies poll poorly...
